Novo Nordisk has asked the FDA to dam creation of compounded copies of copyright, arguing that it’s much too tricky to do safely. It’s the latest escalation in the brewing war between pharmaceutical companies and compounders.Cannabis-derived merchandise: Continue being illegal underneath federal law, but may be legal under selected state guidel